ES2029776T1 - Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad. - Google Patents

Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad.

Info

Publication number
ES2029776T1
ES2029776T1 ES199090106403T ES90106403T ES2029776T1 ES 2029776 T1 ES2029776 T1 ES 2029776T1 ES 199090106403 T ES199090106403 T ES 199090106403T ES 90106403 T ES90106403 T ES 90106403T ES 2029776 T1 ES2029776 T1 ES 2029776T1
Authority
ES
Spain
Prior art keywords
preparation
procedure
pharmaceutical compositions
compositions containing
high stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES199090106403T
Other languages
English (en)
Other versions
ES2029776T3 (es
Inventor
Luigi Moro
Achille Fiori
Alberto Natali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of ES2029776T1 publication Critical patent/ES2029776T1/es
Application granted granted Critical
Publication of ES2029776T3 publication Critical patent/ES2029776T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCESOS PARA LA PREPARACION DE TABLETAS O CAPSULAS DE BROMOCRIPTINA, EN DONDE EL INGREDIENTE ACTIVO ESTA PROTEGIDO POR INCLUSION EN UN EXCIPIENTE O POR GRANULACION SEPARADA DE LOS EXCIPIENTES Y MEZCLADO DEL GRANULADO CON UNA MEZCLA DEL INGREDIENTE ACTIVO Y UN EXCIPIENTE QUE TIENE BAJO CONTENIDO DE HUMEDAD.
ES90106403T 1989-04-07 1990-04-04 Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con gran estabilidad y productos relacionados. Expired - Lifetime ES2029776T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920063A IT1235053B (it) 1989-04-07 1989-04-07 Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.

Publications (2)

Publication Number Publication Date
ES2029776T1 true ES2029776T1 (es) 1992-10-01
ES2029776T3 ES2029776T3 (es) 1995-02-01

Family

ID=11163518

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90106403T Expired - Lifetime ES2029776T3 (es) 1989-04-07 1990-04-04 Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con gran estabilidad y productos relacionados.

Country Status (9)

Country Link
US (1) US5066495A (es)
EP (1) EP0391374B1 (es)
AT (1) ATE114968T1 (es)
DD (1) DD293961B5 (es)
DE (2) DE391374T1 (es)
DK (1) DK0391374T3 (es)
ES (1) ES2029776T3 (es)
GR (1) GR900300172T1 (es)
IT (1) IT1235053B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6129931A (en) * 1998-09-03 2000-10-10 Isp Investments Inc. Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
US8226972B2 (en) * 2001-12-20 2012-07-24 Femmepharma Holding Company, Inc. Vaginal delivery of drugs
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
AU2004203700B2 (en) * 2003-01-02 2007-06-21 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
AU2007216882B2 (en) * 2003-01-02 2010-03-11 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatment of diseases and disorders of the breast
WO2008083158A2 (en) * 2006-12-26 2008-07-10 Femmepharma Holding Company, Inc. Topical administration of danazol
GB0715628D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Solid valsartan composition
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US8431155B1 (en) 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
CN105640901A (zh) * 2014-11-10 2016-06-08 匈牙利吉瑞大药厂 一种利用新型生产工艺制备甲磺酸溴隐亭片的方法及其应用
WO2017184875A1 (en) 2016-04-20 2017-10-26 Veroscience Llc Composition and method for treating metabolic disorders
CA3079522A1 (en) 2017-10-18 2019-04-25 Veroscience Llc Improved bromocriptine formulations
CN117323305B (zh) * 2023-11-07 2024-06-07 杭州沐源生物医药科技有限公司 溴隐亭片剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627516A (es) * 1962-01-25
US3836618A (en) * 1971-12-23 1974-09-17 American Home Prod Process for the uniform distribution of a drug on a granulated base
NL7314066A (es) * 1972-10-18 1974-04-22
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
GR79340B (es) * 1982-07-06 1984-10-22 Sterwin Ag
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
US5066495A (en) 1991-11-19
ES2029776T3 (es) 1995-02-01
DE391374T1 (de) 1991-02-28
DK0391374T3 (da) 1995-04-24
ATE114968T1 (de) 1994-12-15
EP0391374B1 (en) 1994-12-07
EP0391374A2 (en) 1990-10-10
IT8920063A0 (it) 1989-04-07
DE69014691D1 (de) 1995-01-19
IT1235053B (it) 1992-06-17
DE69014691T2 (de) 1995-04-20
EP0391374A3 (en) 1992-07-01
GR900300172T1 (en) 1991-09-27
DD293961B5 (de) 1994-11-10

Similar Documents

Publication Publication Date Title
ES2029776T1 (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad.
ES2187822T3 (es) Comprimidos de disgregacion rapida.
ES2061623T3 (es) Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
ES2161690T3 (es) Formulaciones farmaceuticas.
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
MX9205208A (es) Compuestos derivados del acido 5-amino-4-hidroxihexanoico, procedimiento para su preparacion y compociciones farmaceuticas que los contienen
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
SV2001000125A (es) Procedimiento para la obtencion de preparados farmaceuticos solidos de disgregacion rapida ref.lea 33801-sv
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
ES535798A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina.
MX9303572A (es) Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene.
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
ES2076975T3 (es) Aspirina en dosis baja con liberacion controlada.
AR021576A1 (es) Analogos del peptido 1-similar al glucagon, uso de los mismos para la manufactura de un medicamento y composiciones farmaceuticas que los contienen.
AR005456A1 (es) Comprimidos y tabletas farmaceuticas que contienen 2-(2-(2-amino-9h-purin-9-il)etil)-1,3-propanodiol diacetato (famcicloviri) yprocedimiento para obtenerlos
SE8002244L (sv) Nytt 1alfa,25-dihydroxi-cholekalciferolderivat, sett for framstellning samt anvendning derav som lekemedel och farmaceutiska kompositioner inehallande denna forening
ES2051898T3 (es) Composicion farmaceutica para 4-aroilimidazol-2-onas.
MX9203068A (es) Compuestos activirales oralmente activos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 391374

Country of ref document: ES